Abiopharma

Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

HCI Group Announces Completion of its 2026-2027 Catastrophe Reinsurance Programs

XCharge Appoints Albina Iljasov as Co-Chief Executive Officer

FLUENT Reports First Quarter 2026 Results

New Era Energy & Digital Announces Upcoming Conference Participation and Expected Russell Index Inclusion

Edible Garden Accelerates Path to Profitability Through Major Logistics Transformation, Reducing Operating Costs, Lowering Emissions and Enhancing Supply Chain Efficiency

Dormant shares - change in the number of shares

Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML

Piedmont REIT Signs 240,000 SF of Leases Second Quarter-to-Date Bringing YTD Leasing to approximately 670,000 SF